Like CD24, some of these markers are already used as predictive biomarkers for certain types of cancer such as CRYAB,106HSPA6,107,108, GDF-15109,110, and somatostatin (SST)111 and thus may offer potential biomarkers to predict drug-related effects in retinal organoids. This evidence concerns the gene CD24 and cancer.